Form 8-K CURIS INC For: Nov 09

Go back to Form 8-K CURIS INC For: Nov 09

Curis (CRIS) Outpaces in Q3; Roth Affirms 'Buy' Rating Ahead of ASH

November 9, 2015 2:54 PM EST

Roth Capital reaffirms Curis (Nasdaq: CRIS) with a Buy rating and $5 price target following Q3 results and update issued earlier Monday.

Analyst Joseph Pantginis noted that Curis posted Q3 loss of $0.04 per share, versus the firm's outlook calling for a loss of $0.08 per share.

Pantginis continued, INDs for both licensed programs from Aurigene are... More

Curis (CRIS) Tops Q3 EPS by 4c

November 9, 2015 8:19 AM EST

Curis (NASDAQ: CRIS) reported Q3 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.82 million.

For earnings history and earnings-related data on Curis (CRIS) click here.

... More